Isosorbide Dinitrate Extended-Release Tablet

Isosorbide Dinitrate Extended-Release Tablet

Categories : Cardiovascular System

Product Packaging : 10 / 30 tablets

Product Composition : 20 mg

Send Message

Isosorbide Dinitrate Extended-Release Tablets are used for the prevention and long-term management of angina pectoris associated with coronary artery disease. The extended-release formulation provides a sustained therapeutic effect, helping improve blood flow and reduce the frequency of anginal attacks. Genliva Wellness LLP offers high-quality Isosorbide Dinitrate Extended-Release Tablets for Global Healthcare Markets.

This medication works by relaxing and widening blood vessels, thereby reducing the workload on the heart and improving oxygen supply to cardiac tissues. As a trusted Isosorbide Dinitrate Extended-Release Tablet Exporter from India, we supply quality cardiovascular formulations to pharmaceutical distributors and healthcare providers worldwide.

Manufactured under stringent quality standards, the product ensures consistent drug release and reliable therapeutic performance. Genliva Wellness LLP is a dependable Isosorbide Dinitrate Extended-Release Tablet Manufacturer in India serving international pharmaceutical markets with premium-quality cardiac care products.

Isosorbide Dinitrate Extended-Release Tablets are formulated to provide sustained nitrate therapy for long-term angina management.

  • Extended-release tablet formulation
  • Contains Isosorbide Dinitrate as the active ingredient
  • Provides prolonged therapeutic effect
  • Supports consistent drug release
  • Suitable for long-term cardiovascular therapy
  • Stable and reliable formulation

Isosorbide Dinitrate Extended-Release Tablets are used for the prevention and management of ischemic heart conditions.

  • Prevention of angina pectoris
  • Long-term management of coronary artery disease
  • Chronic stable angina
  • Reduction of chest pain episodes
  • Improvement of cardiac oxygen supply
  • Cardiovascular disease management

The extended-release formulation helps provide continuous symptom control and improved patient convenience.

  • Prolonged duration of action
  • Helps reduce frequency of angina attacks
  • Improves blood flow to the heart
  • Supports long-term cardiovascular care
  • Convenient dosing schedule
  • Well-established therapeutic efficacy

whatsapp-app